WEDNESDAY, Nov. 13, 2019 (HealthDay News) — Here’s some worrisome news for folks who manage to survive a heart attack: New research suggests they might be far more vulnerable to developing cancer down the road.
People who suffered a heart health scare — a heart attack, heart failure or a dangerously erratic heart rhythm — had a more than sevenfold increased risk for subsequently developing cancer, compared to those with healthy tickers, researchers said.
“We found that folks with certain risk factors for heart disease had an increased risk of cancer and, more intriguingly, we found up that individuals who ended up developing heart disease had a significantly increased risk of future cancer,” said lead researcher Dr. Emily Lau, a cardiology fellow at Massachusetts General Hospital in Boston.
These findings are based on data from the Framingham Heart Study, a famous decades-long research project following the heart health of people living in the small town of Framingham, Mass.
Lau and her colleagues had noticed that many regular patients with heart disease were also fighting cancer.
The researchers turned to the Framingham study, tracking more than 12,700 people for about 15 years who had neither heart disease nor cancer at the start of the study.
During the study period, 1,670 cancer cases occurred — mainly gastrointestinal, breast, prostate and lung.
People starting out with risk factors that gave them a 20% risk of heart disease over the next decade were more than three times as likely as those with a lower risk to develop any type of cancer, researchers found.
The most important risk factors shared between the two diseases were age, high blood pressure, diabetes and smoking, Lau said.
Even more striking, people who suffered a heart attack or heart failure then had a drastically increased risk of cancer.
Researchers also found that people with high levels of BNP, a hormone frequently elevated in heart failure, were more likely to develop cancer.
Heart disease and cancer share many risk factors, so it’s very likely that folks who develop one would then suffer from the other, said Lau and Dr. Nicholas Rohs, an assistant professor of medical oncology at the Blavatnik Family-Chelsea Medical Center at Mount Sinai in New York City.